CDKN1C and neoplasm: miR-221 targets key tumor suppressors, including CDKN1B/p27 [310,311,312], CDKN1C/p57 [313,314], PTEN [315], TIMP3 [315], and DNA damage-inducible transcript 4 (DDIT4) [260].